GIP Protein (AA 22-85) (Fc Tag)

Catalog No. ABIN7274749

Product Details

Target: GIP (Gastric Inhibitory Polypeptide (GIP))

Protein Type: Recombinant

Protein Characteristics: AA 22-85

Origin: Mouse

Source: HEK-293 Cells

Purification tag / Conjugate: This GIP protein is labelled with Fc Tag.

Purpose: Mouse GIP Protein

Sequence: Glu22-Gln85

Characteristics: Recombinant Mouse GIP Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Glu22-Gln85.

Purity: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Sterility: 0.22 μm filtered

Endotoxin Level: Less than 1EU per μg by the LAL method.

Application Details

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Expiry Date: 12 months

Target Details

Target: GIP (Gastric Inhibitory Polypeptide (GIP))

Alternative Name: GIP (GIP Products)

Background: The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals.

Molecular Weight: 34.3 kDa. Due to glycosylation, the protein migrates to 40-45 kDa based on Tris-Bis PAGE result.

UniProt: P48756

Pathways: Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism